Radiopharm Theranostics Ltd ADR (RADX)

$16.19 +10.59 (189.11%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 10,245
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; a...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3, Carlton, Australia
OldManLogan
OldManLogan May. 13 at 5:18 PM
$RADX Will be very interesting to see what happens in the weeks ahead; last interim data on RAD101 generated a MASSSSIVE but short-lived spike; now with multiple data releases pending for 'mid-2026' and the possibility of a partner for phase III, does this spike and then settle in to a much higher trading range as it waits for the next catalyst...
0 · Reply
athebeast
athebeast May. 13 at 5:12 PM
$RADX 🤣🤣🤣🤣🤣🤣🤣🤣 Bagholder city. This will be dead money forever. Will drop under $4.X in the next upcoming weeks. Don't say you weren't warned. 🔻🔻🔻🔻
0 · Reply
athebeast
athebeast May. 13 at 5:11 PM
$RADX Less than 1% chances that's happening
0 · Reply
lapulce02
lapulce02 May. 13 at 4:48 PM
$RADX @Busa7 ready for 20usd or 50usd tp?
2 · Reply
RadioIsotope25
RadioIsotope25 May. 13 at 4:47 PM
$RADX Data will kill the shorts. Won’t be dead money in a few weeks
0 · Reply
GreenorGo
GreenorGo May. 13 at 4:43 PM
$RADX Dead money until something happens
2 · Reply
RadioIsotope25
RadioIsotope25 May. 13 at 4:40 PM
$RADX Go Lantheus it’s your birthday $96 $LNTH
0 · Reply
RadioIsotope25
RadioIsotope25 May. 13 at 4:38 PM
$RADX Buyer keeps refreshing bid
0 · Reply
StJohn_TudorJones
StJohn_TudorJones May. 13 at 3:35 PM
$RADX this price action on relatively timid total volume — also means very few sellers here
0 · Reply
StJohn_TudorJones
StJohn_TudorJones May. 13 at 3:24 PM
$RADX RAD101 30th patient’s data realistically could be finalized by now / they could know full picture of what they’re looking at … one can speculate 🧐😉
1 · Reply
Latest News on RADX
Radiopharm Theranostics Transcript: Deutsche Bank ADR Virtual Investor Conference

Apr 28, 2026, 12:00 PM EDT - 15 days ago

Radiopharm Theranostics Transcript: Deutsche Bank ADR Virtual Investor Conference

Radiopharm Theranostics Reports Business Update

Thu, 23 Apr 2026 07:00:00 -0400 - 20 days ago

Radiopharm Theranostics Reports Business Update

Radiopharm announces new data from Phase 0/1 HEAT trial

2026-04-20T12:08:59.000Z - 23 days ago

Radiopharm announces new data from Phase 0/1 HEAT trial

Radiopharm gets DSMC recommendation to advance 177Lu-RAD202 to next dose

2026-04-08T11:45:06.000Z - 5 weeks ago

Radiopharm gets DSMC recommendation to advance 177Lu-RAD202 to next dose

Radiopharm Theranostics Signs Supply Deal With Siemens Healthineers For RAD101

2026-04-07T12:01:22.000Z - 5 weeks ago

Radiopharm Theranostics Signs Supply Deal With Siemens Healthineers For RAD101

Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.

Tue, 07 Apr 2026 07:00:00 -0400 - 5 weeks ago

Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.

Biotech Alert: Searches spiking for these stocks today

2026-03-27T15:36:04.000Z - 6 weeks ago

Biotech Alert: Searches spiking for these stocks today

SMMT SPRB

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

Fri, 27 Mar 2026 07:00:00 -0400 - 6 weeks ago

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

Biotech Alert: Searches spiking for these stocks today

2026-03-26T15:41:23.000Z - 6 weeks ago

Biotech Alert: Searches spiking for these stocks today

Radiopharm Theranostics Transcript: Study result

Mar 24, 2026, 6:00 PM EDT - 7 weeks ago

Radiopharm Theranostics Transcript: Study result

Radiopharm Theranostics Transcript: NWR Virtual Healthcare Conference

Mar 24, 2026, 5:30 PM EDT - 7 weeks ago

Radiopharm Theranostics Transcript: NWR Virtual Healthcare Conference

Radiopharm Theranostics Eyes Pivotal Trial Path After Encouraging Interim Results

Tue, 24 Mar 2026 10:56:48 -0400 - 7 weeks ago

Radiopharm Theranostics Eyes Pivotal Trial Path After Encouraging Interim Results

Radiopharm doses first patient in Phase 1/2a study of BetaBart

2026-02-24T12:54:28.000Z - 2 months ago

Radiopharm doses first patient in Phase 1/2a study of BetaBart

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

Wed, 28 Jan 2026 07:00:00 -0500 - 3 months ago

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

Radiopharm Theranostics Transcript: Emerging Growth Conference 89

Jan 21, 2026, 9:05 AM EST - 4 months ago

Radiopharm Theranostics Transcript: Emerging Growth Conference 89

Radiopharm increases ownership in Radiopharm Ventures to 87.5%

2026-01-12T12:41:55.000Z - 4 months ago

Radiopharm increases ownership in Radiopharm Ventures to 87.5%

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Mon, 12 Jan 2026 07:00:00 -0500 - 4 months ago

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Biotech Alert: Searches spiking for these stocks today

2025-12-17T16:40:22.000Z - 5 months ago

Biotech Alert: Searches spiking for these stocks today

AIM

Radiopharm price target raised to $15 from $12 at Maxim

2025-12-17T13:50:36.000Z - 5 months ago

Radiopharm price target raised to $15 from $12 at Maxim

Biotech Alert: Searches spiking for these stocks today

2025-12-16T17:10:30.000Z - 5 months ago

Biotech Alert: Searches spiking for these stocks today

Radiopharm price target raised to $16 from $13 at B. Riley

2025-12-16T13:00:34.000Z - 5 months ago

Radiopharm price target raised to $16 from $13 at B. Riley

Radiopharm Theranostics Transcript: Study Update

Dec 15, 2025, 6:00 PM EST - 5 months ago

Radiopharm Theranostics Transcript: Study Update

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Mon, 15 Dec 2025 11:59:59 -0500 - 5 months ago

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Why Is Radiopharm Theranostics Stock (RADX) Up Today?

2025-12-15T12:34:24.000Z - 5 months ago

Why Is Radiopharm Theranostics Stock (RADX) Up Today?

Radiopharm achieves primary endpoint in 92% of patients in RAD 101 trial

2025-12-15T12:05:27.000Z - 5 months ago

Radiopharm achieves primary endpoint in 92% of patients in RAD 101 trial

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Mon, 15 Dec 2025 07:00:00 -0500 - 5 months ago

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Radiopharm Theranostics (RADX): Analyst Maintains 'Buy' as Price Target Adjusts | RADX Stock News

2025-11-26T18:34:17.000Z - 5 months ago

Radiopharm Theranostics (RADX): Analyst Maintains 'Buy' as Price Target Adjusts | RADX Stock News

Radiopharm price target lowered to $13 from $15 at B. Riley

2025-11-26T14:20:48.000Z - 6 months ago

Radiopharm price target lowered to $13 from $15 at B. Riley

Radiopharm receives approval to initiate Phase 1 trial of RAD 402

2025-11-18T14:45:09.000Z - 6 months ago

Radiopharm receives approval to initiate Phase 1 trial of RAD 402

Radiopharm announces 50% enrollment in Phase 2b trial of RAD101

2025-11-17T13:21:04.000Z - 6 months ago

Radiopharm announces 50% enrollment in Phase 2b trial of RAD101

Radiopharm starts enrollment of third cohort in Phase 1 trial of 177Lu-RAD204

2025-11-12T13:35:22.000Z - 6 months ago

Radiopharm starts enrollment of third cohort in Phase 1 trial of 177Lu-RAD204

Radiopharm Theranostics Transcript: Deutsche Bank ADR Virtual Investor Conference 2025

Nov 4, 2025, 12:30 PM EST - 6 months ago

Radiopharm Theranostics Transcript: Deutsche Bank ADR Virtual Investor Conference 2025

Lantheus (LNTH) Commits to Significant Investment in Radiopharm Theranostics

2025-10-20T13:30:38.000Z - 7 months ago

Lantheus (LNTH) Commits to Significant Investment in Radiopharm Theranostics

Radiopharm provides update on pipeline of clinical programs

2025-10-20T12:10:31.000Z - 7 months ago

Radiopharm provides update on pipeline of clinical programs

Radiopharm launches A$5M share purchase plan

2025-10-20T11:41:07.000Z - 7 months ago

Radiopharm launches A$5M share purchase plan

LNTH

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Mon, 20 Oct 2025 07:30:00 -0400 - 7 months ago

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Regal-backed biotech Radiopharm Theranostics launches $35m placement

2025-10-15T23:01:20.000Z - 7 months ago

Regal-backed biotech Radiopharm Theranostics launches $35m placement

Radiopharm Theranostics trading halted, volatility trading pause

2025-10-13T16:40:26.000Z - 7 months ago

Radiopharm Theranostics trading halted, volatility trading pause

RADX

Radiopharm Theranostics trading resumes

2025-10-13T16:40:07.000Z - 7 months ago

Radiopharm Theranostics trading resumes

RADX

Radiopharm Theranostics Transcript: KOL Event

Sep 24, 2025, 8:30 PM EDT - 8 months ago

Radiopharm Theranostics Transcript: KOL Event

Radiopharm Theranostics Transcript: KOL Event

Sep 1, 2025, 8:30 PM EDT - 9 months ago

Radiopharm Theranostics Transcript: KOL Event

Radiopharm Theranostics Transcript: KOL Event

Aug 26, 2025, 8:30 PM EDT - 9 months ago

Radiopharm Theranostics Transcript: KOL Event

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Tue, 29 Jul 2025 07:30:00 -0400 - 10 months ago

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Tue, 22 Jul 2025 08:00:00 -0400 - 10 months ago

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

Mon, 02 Jun 2025 08:00:00 -0400 - 1 year ago

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Mon, 19 May 2025 08:00:00 -0400 - 1 year ago

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Radiopharm Theranostics Transcript: NWR Virtual Healthcare Conference

Mar 18, 2025, 6:40 PM EDT - 1 year ago

Radiopharm Theranostics Transcript: NWR Virtual Healthcare Conference

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

2025-03-12T16:57:48.000Z - 1 year ago

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Radiopharm Theranostics Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 4, 2025, 9:10 AM EST - 1 year ago

Radiopharm Theranostics Transcript: TD Cowen 45th Annual Healthcare Conference

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

Mon, 30 Dec 2024 08:00:00 -0500 - 1 year ago

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Dec 20, 2024, 8:00 AM EST - 1 year ago

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

Sep 19, 2024, 12:00 PM EDT - 1 year ago

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

DB

OldManLogan
OldManLogan May. 13 at 5:18 PM
$RADX Will be very interesting to see what happens in the weeks ahead; last interim data on RAD101 generated a MASSSSIVE but short-lived spike; now with multiple data releases pending for 'mid-2026' and the possibility of a partner for phase III, does this spike and then settle in to a much higher trading range as it waits for the next catalyst...
0 · Reply
athebeast
athebeast May. 13 at 5:12 PM
$RADX 🤣🤣🤣🤣🤣🤣🤣🤣 Bagholder city. This will be dead money forever. Will drop under $4.X in the next upcoming weeks. Don't say you weren't warned. 🔻🔻🔻🔻
0 · Reply
athebeast
athebeast May. 13 at 5:11 PM
$RADX Less than 1% chances that's happening
0 · Reply
lapulce02
lapulce02 May. 13 at 4:48 PM
$RADX @Busa7 ready for 20usd or 50usd tp?
2 · Reply
RadioIsotope25
RadioIsotope25 May. 13 at 4:47 PM
$RADX Data will kill the shorts. Won’t be dead money in a few weeks
0 · Reply
GreenorGo
GreenorGo May. 13 at 4:43 PM
$RADX Dead money until something happens
2 · Reply
RadioIsotope25
RadioIsotope25 May. 13 at 4:40 PM
$RADX Go Lantheus it’s your birthday $96 $LNTH
0 · Reply
RadioIsotope25
RadioIsotope25 May. 13 at 4:38 PM
$RADX Buyer keeps refreshing bid
0 · Reply
StJohn_TudorJones
StJohn_TudorJones May. 13 at 3:35 PM
$RADX this price action on relatively timid total volume — also means very few sellers here
0 · Reply
StJohn_TudorJones
StJohn_TudorJones May. 13 at 3:24 PM
$RADX RAD101 30th patient’s data realistically could be finalized by now / they could know full picture of what they’re looking at … one can speculate 🧐😉
1 · Reply
Lalalilala
Lalalilala May. 13 at 3:00 PM
$RADX 4,54$ !! 😀😁☺️🤗🤗🤗
1 · Reply
Lalalilala
Lalalilala May. 13 at 2:42 PM
$RADX We're taking it slow but steady... I'm at breakeven at $4.53... very happy to have added a little to $4! There's still a bit of a lack of volume and we're still below the 10, 20, 60, and 120 EMAs, so we're in a downtrend... We need to break through to 4.50/4.55 to enter a reversal phase, and I hope we'll be there tonight!
1 · Reply
alsworthg
alsworthg May. 12 at 8:39 PM
$RADX wouldn't hate it if the low float pumpers showed up here
0 · Reply
Manpreet00
Manpreet00 May. 12 at 8:06 PM
$RADX looks like it’s waking up. The CEO better make it worth our while. We have been through enough
0 · Reply
Lalalilala
Lalalilala May. 12 at 7:52 PM
$RADX I just rounded up to 18,000 shares. 😬😬😬 I'm really stopping now....
0 · Reply
RadioIsotope25
RadioIsotope25 May. 12 at 6:51 PM
$RADX
0 · Reply
StJohn_TudorJones
StJohn_TudorJones May. 12 at 6:36 PM
$RADX strong-volume bounce off $4 continues, even better that it indeed looks like a fund entering —strong volume & 60k buy-candle yesterday
2 · Reply
Manpreet00
Manpreet00 May. 12 at 6:33 PM
$RADX locked and loaded. Not selling till $20/share . Might have to wait till end of the year when HER2 data comes out. I think RAD101 will push it past $10 next month
1 · Reply
lapulce02
lapulce02 May. 12 at 6:18 PM
$RADX 👀 @Busa7 add here
0 · Reply
Lalalilala
Lalalilala May. 12 at 4:27 PM
$RADX I've closed my position... slightly higher than in December but $1 less in cost basis ($4.55). I hope to go above $13 this time! A group announcement, as mentioned in a post above... results exceeding expectations, a solid partnership, private funding to continue Phase 3 of RAD101 as well as the trials already underway... (I'd prefer they didn't communicate outside of market hours this time!! I sent an email to their "Investor Relations" page specifically requesting that they issue the announcement so that every shareholder has an equal opportunity to buy or sell!) Tired of having to sell at $13 when you see $21 in pre-market trading!!! 🙄😅😅😅 Good luck to everyone! I'm expecting volume and above 150,000 shares every day!
0 · Reply
Lalalilala
Lalalilala May. 12 at 4:08 PM
$RADX Added
0 · Reply
RadioIsotope25
RadioIsotope25 May. 12 at 3:23 PM
$RADX Looks like biotech fund establishing 500,000 share position
1 · Reply